리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2024년 10월
페이지 정보:영문 179 Pages
라이선스 & 가격 (부가세 별도)
한글목차
2030년까지 핵산 표지 세계 시장 규모는 48억 달러에 달할 것으로 전망
2023년 29억 달러로 추정되는 핵산 표지 세계 시장은 2023년부터 2030년까지 연평균 7.5% 성장하여 2030년에는 48억 달러에 달할 것으로 예상됩니다. 핵산 표지 시약은 이 보고서에서 분석한 부문 중 하나이며, CAGR 8.3%를 기록하여 분석 기간이 끝날 때 24억 달러에 도달할 것으로 예상됩니다. 핵산 표지 키트 분야의 성장률은 분석 기간 동안 CAGR 7.2%로 추정됩니다.
미국 시장 7억 9,750만 달러로 추정, 중국은 CAGR 6.9%로 성장 전망
미국 핵산 라벨링 시장은 2023년 7억 9,750만 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2023-2030년 분석 기간 동안 6.9%의 CAGR을 기록하며 2030년까지 7억 3,710만 달러의 시장 규모에 도달할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 7.0%와 6.1%의 CAGR을 기록할 것으로 예상됩니다. 유럽에서는 독일이 약 6.0%의 CAGR로 성장할 것으로 예상됩니다.
세계 핵산 표지 시장 - 주요 동향 및 촉진요인 요약
현대 분자생물학에서 핵산 표지가 중요한 이유는 무엇인가?
핵산 표지화는 분자생물학 및 생명공학에서 중요한 과정으로, 다양한 연구 및 진단 응용 분야에서 DNA, RNA 및 기타 핵산을 검출, 시각화 및 정량화할 수 있도록 합니다. 표지에는 형광, 방사성, 효소 표지 등이 있으며, in situ hybridization, PCR, 마이크로어레이, 시퀀싱 등의 기술에 사용됩니다. 이러한 표지 기술은 유전자 발현 연구, 유전자 돌연변이 검출, 분자 간 상호 작용을 상세하게 이해하는 데 필수적입니다. 유전체학 및 정밀의료 연구가 가속화됨에 따라 정확성과 민감도가 가장 중요한 임상 진단과 생명과학 연구 모두에서 핵산 표지법이 점점 더 중요해지고 있습니다.
기술의 발전은 어떻게 핵산 표지 시장을 형성하고 있는가?
핵산 표지 기술의 발전은 연구 및 임상 응용 분야의 성장을 촉진하고 있습니다. 형광 표지 및 염료 화학의 혁신은 검출 기술의 민감도와 특이성을 향상시켜 보다 명확하고 정확한 결과를 가능하게 합니다. 차세대 라벨링 키트와 시약은 또한 프로세스를 간소화하고 기존 라벨링 방법에 수반되는 시간과 복잡성을 줄여주고 있습니다. 또한, 자동 라벨링 시스템은 대규모 유전체 연구 및 제약 연구와 같은 고처리량 환경에서 인기를 얻고 있습니다. 이러한 발전은 핵산 라벨링 공정의 효율성과 확장성을 향상시켜 실험실에서 더 많은 양의 샘플과 더 복잡한 실험을 더 쉽게 처리할 수 있도록 돕고 있습니다.
유전체학 및 진단학의 부상은 핵산 표지에 어떤 영향을 미칠 것인가?
유전체학 및 맞춤의료에 대한 관심이 높아지면서 핵산 표지 시장에 큰 영향을 미치고 있습니다. 유전자 시퀀싱과 분자진단이 헬스케어에 필수적인 요소로 자리 잡으면서 정확하고 효율적인 핵산 표지 방법에 대한 수요가 증가하고 있습니다. 임상 진단에서 표지된 핵산은 유전성 질환, 감염성 질환, 암을 검출하는 데 필수적이며, 효과적인 치료법을 결정하기 위해서는 정확도가 중요합니다. 또한, 차세대 염기서열 분석(NGS) 및 크리스퍼(CRISPR) 기반 유전자 편집과 같은 하이스루풋 기술의 성장으로 유전물질의 대규모 및 신속한 분석을 지원할 수 있는 고급 표지 기술에 대한 요구가 증가하고 있습니다. 이러한 추세는 유전체학 연구에 대한 투자 증가와 바이오의약품 혁신의 부상으로 인해 더욱 가속화되고 있습니다.
핵산 표지 시장의 성장은 몇 가지 요인에 의해 이루어집니다.
핵산 표지 시장의 성장은 분자생물학 기술의 발전, 유전체학의 응용 확대, 고정밀 진단 도구에 대한 수요 증가 등 여러 요인에 의해 주도되고 있습니다. 차세대 염기서열 분석(NGS) 기술의 보급과 개인 맞춤형 의료의 확산으로 고급 핵산 표지법에 대한 수요가 증가하고 있습니다. 형광 및 효소 표지 기술 혁신은 연구와 임상 모두에서 보다 신속하고 정확한 결과를 가능하게 하고 있습니다. 또한, 자동화된 고처리량 라벨링 시스템의 채택이 증가하면서 실험실 워크플로우의 효율성이 향상되고 있습니다. 암 진단, 유전성 질환, 감염성 병원체에 대한 연구가 증가함에 따라 신속하고 민감한 핵산 검출 및 분석을 지원하는 라벨링 기술에 대한 수요가 더욱 증가하고 있습니다. 유전체 연구와 헬스케어 발전에 대한 정부의 재정적 지원도 시장 확대에 기여하고 있습니다.
조사 대상 기업 예시(주목할 만한 12개 기업)
Agilent Technologies, Inc.
Enzo Biochem, Inc.
F. Hoffmann-La Roche AG
General Electric Company
Merck KgaA
New England Biolabs, Inc.
PerkinElmer, Inc.
Promega Corporation
Thermo Fisher Scientific, Inc.
Vector Laboratories, Inc.
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 성장 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
기타 유럽
아시아태평양
기타 지역
제4장 경쟁
ksm
영문 목차
영문목차
Global Nucleic Acid Labeling Market to Reach US$4.8 Billion by 2030
The global market for Nucleic Acid Labeling estimated at US$2.9 Billion in the year 2023, is expected to reach US$4.8 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Nucleic Acid Labeling Reagents, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$2.4 Billion by the end of the analysis period. Growth in the Nucleic Acid Labeling Kits segment is estimated at 7.2% CAGR over the analysis period.
The U.S. Market is Estimated at US$797.5 Million While China is Forecast to Grow at 6.9% CAGR
The Nucleic Acid Labeling market in the U.S. is estimated at US$797.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$737.1 Million by the year 2030 trailing a CAGR of 6.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.0% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.0% CAGR.
Why Is Nucleic Acid Labeling Important in Modern Molecular Biology?
Nucleic acid labeling is a crucial process in molecular biology and biotechnology, enabling the detection, visualization, and quantification of DNA, RNA, and other nucleic acids in various research and diagnostic applications. Labels can be fluorescent, radioactive, or enzymatic, and they are used in techniques such as in situ hybridization, PCR, microarrays, and sequencing. These labeling techniques are essential for studying gene expression, detecting genetic mutations, and understanding molecular interactions at a detailed level. As research in genomics and precision medicine accelerates, nucleic acid labeling is becoming increasingly critical in both clinical diagnostics and life sciences research, where accuracy and sensitivity are paramount.
How Are Technological Advancements Shaping the Nucleic Acid Labeling Market?
Technological advancements in nucleic acid labeling are driving growth in both research and clinical applications. Innovations in fluorescent labeling and dye chemistry are enhancing the sensitivity and specificity of detection techniques, allowing for clearer and more accurate results. Next-generation labeling kits and reagents are also simplifying the process, reducing the time and complexity involved in traditional labeling methods. Additionally, automated labeling systems are gaining popularity in high-throughput environments, such as large-scale genomic studies and pharmaceutical research. These advancements are improving the efficiency and scalability of nucleic acid labeling processes, making it easier for laboratories to handle larger sample volumes and more complex experiments.
What Impact Does the Rise of Genomics and Diagnostics Have on Nucleic Acid Labeling?
The increasing focus on genomics and personalized medicine is significantly influencing the nucleic acid labeling market. As genetic sequencing and molecular diagnostics become more integral to healthcare, the demand for accurate and efficient nucleic acid labeling methods is rising. In clinical diagnostics, labeled nucleic acids are essential for detecting genetic disorders, infectious diseases, and cancers, where precision is critical for effective treatment decisions. In addition, the growth of high-throughput technologies, such as next-generation sequencing (NGS) and CRISPR-based gene editing, is expanding the need for advanced labeling techniques that can support large-scale, rapid analysis of genetic material. This trend is also being driven by increasing investments in genomics research and the rise of biopharmaceutical innovations.
Growth in the Nucleic Acid Labeling Market Is Driven by Several Factors
Growth in the nucleic acid labeling market is driven by several factors, including advancements in molecular biology techniques, the expanding application of genomics, and the rising demand for high-precision diagnostic tools. The proliferation of next-generation sequencing (NGS) technologies and the growing use of personalized medicine are increasing the need for sophisticated nucleic acid labeling methods. Technological innovations in fluorescent and enzymatic labeling are enabling faster, more accurate results in both research and clinical settings. Additionally, the increasing adoption of automated and high-throughput labeling systems is enhancing workflow efficiency in laboratories. Growing research into cancer diagnostics, genetic diseases, and infectious pathogens is further fueling demand for labeling technologies that support rapid, sensitive nucleic acid detection and analysis. Government funding for genomics research and healthcare advancements is also contributing to the market’s expansion.
Select Competitors (Total 12 Featured) -
Agilent Technologies, Inc.
Enzo Biochem, Inc.
F. Hoffmann-La Roche AG
General Electric Company
Merck KgaA
New England Biolabs, Inc.
PerkinElmer, Inc.
Promega Corporation
Thermo Fisher Scientific, Inc.
Vector Laboratories, Inc.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Nucleic Acid Labeling - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increasing Demand for Molecular Diagnostics and Research Drives Growth in Nucleic Acid Labeling Applications
Advances in Fluorescent and Radioactive Labeling Technologies Expand Opportunities in DNA/RNA Labeling for Diagnostics
Rising Use of Nucleic Acid Labeling in Next-Generation Sequencing (NGS) and PCR Amplification Fuels Market Demand
Expanding Role of Genetic and Epigenetic Research Spurs the Adoption of Novel Nucleic Acid Labeling Methods
Growing Importance of Gene Expression Profiling Strengthens the Business Case for Labeling Techniques in Transcriptomics
Development of Cost-Effective and High-Sensitivity Labeling Kits Propels Growth in Clinical and Research Applications
Increasing Adoption of In-Situ Hybridization (ISH) Techniques Drives Demand for High-Precision Nucleic Acid Labeling
Growing Role of CRISPR-Based Research in Gene Editing Expands the Need for Advanced Nucleic Acid Labeling Technologies
Rising Focus on Personalized Medicine and Biomarker Discovery Spurs Market Demand for Innovative Labeling Solutions
Advances in Non-Radioactive Labeling Techniques Propel Growth in Safe and Environmentally Friendly Labeling Solutions
Rising Use of Labeling in Single-Cell Analysis Strengthens Demand for High-Specificity Nucleic Acid Labeling Kits
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Nucleic Acid Labeling Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 3: World 7-Year Perspective for Nucleic Acid Labeling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 5: World 7-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 6: World Recent Past, Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 7: World 7-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 9: World 7-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 11: World 7-Year Perspective for PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 12: World Recent Past, Current & Future Analysis for Nick Translation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 13: World 7-Year Perspective for Nick Translation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Random Primer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 15: World 7-Year Perspective for Random Primer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for In Vitro Transcription by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 17: World 7-Year Perspective for In Vitro Transcription by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 18: World Recent Past, Current & Future Analysis for Reverse Transcription by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 19: World 7-Year Perspective for Reverse Transcription by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Other Labeling Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 21: World 7-Year Perspective for Other Labeling Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for in Situ Hybridization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 23: World 7-Year Perspective for in Situ Hybridization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 24: World Recent Past, Current & Future Analysis for DNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 25: World 7-Year Perspective for DNA Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction (PCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 27: World 7-Year Perspective for Polymerase Chain Reaction (PCR) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 28: World Recent Past, Current & Future Analysis for Fluorescence in Situ Hybridization (FISH) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 29: World 7-Year Perspective for Fluorescence in Situ Hybridization (FISH) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 30: World Recent Past, Current & Future Analysis for Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 31: World 7-Year Perspective for Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Blotting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 33: World 7-Year Perspective for Blotting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 34: USA Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 35: USA 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
TABLE 36: USA Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 37: USA 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
TABLE 38: USA Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 39: USA 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
CANADA
TABLE 40: Canada Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 41: Canada 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
TABLE 42: Canada Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 43: Canada 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
TABLE 44: Canada Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 45: Canada 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
JAPAN
Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 46: Japan Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 47: Japan 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
TABLE 48: Japan Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 49: Japan 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
TABLE 50: Japan Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: Japan 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
CHINA
Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 52: China Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 53: China 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
TABLE 54: China Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 55: China 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
TABLE 56: China Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: China 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
EUROPE
Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 58: Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 59: Europe 7-Year Perspective for Nucleic Acid Labeling by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
TABLE 60: Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 61: Europe 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
TABLE 62: Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 63: Europe 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
TABLE 64: Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 65: Europe 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
FRANCE
Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 66: France Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 67: France 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
TABLE 68: France Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: France 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
TABLE 70: France Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 71: France 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
GERMANY
Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 72: Germany Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 73: Germany 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
TABLE 74: Germany Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: Germany 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
TABLE 76: Germany Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 77: Germany 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
ITALY
TABLE 78: Italy Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 79: Italy 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
TABLE 80: Italy Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: Italy 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
TABLE 82: Italy Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 83: Italy 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
UNITED KINGDOM
Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 84: UK Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 85: UK 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
TABLE 86: UK Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: UK 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
TABLE 88: UK Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 89: UK 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
REST OF EUROPE
TABLE 90: Rest of Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 91: Rest of Europe 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 93: Rest of Europe 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
TABLE 94: Rest of Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 95: Rest of Europe 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
ASIA-PACIFIC
Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 96: Asia-Pacific Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 97: Asia-Pacific 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 99: Asia-Pacific 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
TABLE 100: Asia-Pacific Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 101: Asia-Pacific 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
REST OF WORLD
TABLE 102: Rest of World Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 103: Rest of World 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
TABLE 104: Rest of World Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 105: Rest of World 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
TABLE 106: Rest of World Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 107: Rest of World 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
